NIH #1UH2CA307747-01
A multimodal liquid biopsy assay to quantify androgen receptor’s somatic alterations in metastatic castration-resistant prostate cancer.
Active
- Amount
- $226K
- Period
- 2026-03-16 → 2028-02-29
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
NIH #5R01EB032725-04
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
- Amount
- $601K
- Period
- 2022-08-15 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01EB032725-03
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
- Amount
- $572K
- Period
- 2022-08-15 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01EB032725-02
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
- Amount
- $519K
- Period
- 2022-08-15 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #1R01EB032725-01A1
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
- Amount
- $547K
- Period
- 2022-08-15 → 2026-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01EB029805-04
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer
- Amount
- $495K
- Period
- 2020-07-15 → 2026-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01CA212097-06
Cell free nucleic acid-based biomarkers in advanced prostate cancer
- Amount
- $569K
- Period
- 2017-08-01 → 2025-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
NIH #5R01EB029805-03
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer
- Amount
- $503K
- Period
- 2020-07-15 → 2024-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01EB029805-02
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer
- Amount
- $506K
- Period
- 2020-07-15 → 2024-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #1R01EB029805-01
Exosome separation and digital resolution detection of blood-based nucleic acid biomarkers for noninvasive therapeutic diagnostics in cancer
- Amount
- $556K
- Period
- 2020-07-15 → 2024-03-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01CA227699-05
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission
- Amount
- $308K
- Period
- 2018-03-19 → 2024-02-29
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01CA212097-05
Cell free nucleic acid-based biomarkers in advanced prostate cancer
- Amount
- $594K
- Period
- 2017-08-01 → 2023-07-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
NIH #7R01CA212097-04
Cell free nucleic acid-based biomarkers in advanced prostate cancer
- Amount
- $501K
- Period
- 2017-08-01 → 2023-07-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at H. LEE MOFFITT CANCER CTR & RES INST
NIH #5R01CA227699-04
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission
- Amount
- $370K
- Period
- 2018-03-19 → 2023-02-28
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
NIH #5R01CA212097-02
Cell free nucleic acid-based biomarkers in advanced prostate cancer
- Amount
- $638K
- Period
- 2017-08-01 → 2022-07-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MEDICAL COLLEGE OF WISCONSIN
NIH #1R01CA212097-01A1
Cell free nucleic acid-based biomarkers in advanced prostate cancer
- Amount
- $664K
- Period
- 2017-08-01 → 2022-07-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MEDICAL COLLEGE OF WISCONSIN
NIH #5R01CA212097-03
Cell free nucleic acid-based biomarkers in advanced prostate cancer
- Amount
- $105K
- Period
- 2017-08-01 → 2019-12-16
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MEDICAL COLLEGE OF WISCONSIN
NIH #5R21CA133536-02
A Proteomics Approach for Identifying Predictive Factors to Androgen Deprivation
- Amount
- $171K
- Period
- 2009-07-16 → 2011-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MAYO CLINIC ROCHESTER
NIH #1R21CA133536-01A1
A Proteomics Approach for Identifying Predictive Factors to Androgen Deprivation
- Amount
- $220K
- Period
- 2009-07-16 → 2011-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MAYO CLINIC ROCHESTER